Skip to content
  • Our Work
    • Fields
      • Cardiology
      • ENT
      • Gastro
      • Orthopedics
      • Ophthalmology
      • Pulmonology
      • Surgical
      • Urology
      • Other
    • Modalities
      • Endoscopy
      • Medical Segmentation
      • Microscopy
      • Ultrasound
  • Success Stories
  • Insights
    • Magazine
    • Upcoming Events
    • Webinars
    • Meetups
    • News
    • Blog
  • The company
    • About us
    • Careers
Menu
  • Our Work
    • Fields
      • Cardiology
      • ENT
      • Gastro
      • Orthopedics
      • Ophthalmology
      • Pulmonology
      • Surgical
      • Urology
      • Other
    • Modalities
      • Endoscopy
      • Medical Segmentation
      • Microscopy
      • Ultrasound
  • Success Stories
  • Insights
    • Magazine
    • Upcoming Events
    • Webinars
    • Meetups
    • News
    • Blog
  • The company
    • About us
    • Careers
Contact

Pulmonary embolism detection

Pulmonary embolism is the obstruction of a blood vessel in the lungs, usually due to a blood clot. It is a very widespread disease, with at least 650,000 cases in the United States every year. It is the third most common cause of death in the US, presenting mortality rates of 25% to 30% when it is not treated in time. Up to 11% of patients die in the first hour following the sudden attack. With proper diagnosis and treatment, 100,000 more patients suffering from pulmonary embolism would survive.
Pulmonary embolism
Typically accompanied by generic symptoms (fever, coughing, chest pain), pulmonary arterial obstructions may cause an increase in the right ventricular afterload, potentially leading to life-threatening effects like dilatation, dysfunction and ischemia of the right ventricle. Timely detection via pulmonary CT angiography is key to reduce mortality risks, requiring thus very short scanning times, which are sometimes difficult to achieve in emergency situations and/or with conscious and breathing patients. The end result of challenging conditions might be inadequate image contrast, leading to misleading or slow diagnosis with dramatic consequences.
For the above reasons, human detection of pulmonary embolism (the dark spots that correspond to pulmonary emboli in CT angiography images) proves often too slow and can immensely benefit from computer-aided pulmonary embolism detection.
The method which RSIP Vision recommends uses a combination of bidimensional and tridimensional image-processing techniques and subsequently a vessel segmentation procedure which reduces the search area for candidate detection to include the emboli and at the same time exclude a large number of false positives. Particularly, it needs to exclude all lookalikes that present the same intensity of pulmonary emboli: lymphoid tissue, parenchymal diseases and partial-volume voxels on the vessel boundary. Also fully embolized vessels are easily missed by traditional segmentation techniques.
Due to the higher brightness of the larger vessels in the lungs, these are the first to be identified; this is done setting a threshold, the intensity of which is determined in function of the contrast enhancement used. The smaller vessels in the lung are excluded from this process of identification, since their lower intensity in CT image renders them too similar to lymphoid tissue.
The algorithm looks for local contrast differences within the vessels beyond the given threshold. These contrast variations are then analyzed and obstructions are segmented. Candidate lesions are selected from partial or complete obstruction segmentation. Finally, the measurements coming from the CT such as shape, size and density of the candidate lesions are computed to filter false positives lesions using a decision tree. The remaining candidate lesions found by the algorithm are then identified and treated individually.
The whole procedure must be performed with extreme care, since the patient’s movements, image noise or simply bad quality of the pulmonary CT angiography can have a negative impact on the results, by increasing false positives and excluding pulmonary embolism wherever it should not be found. Also poorly timed contrast injection can preclude the chance from the algorithm to correctly detect the nature of intravascular contrast differences. Statistically, veins, airspace consolidation and lymphoid tissue are the main objects of misinterpretations of contrast differences leading to false positive findings. The always improving image quality of modern computed tomography devices is helping this very effective algorithm procedure to keep false positives to a minimum and by this way it contributes to reduce the dramatic mortality rates of pulmonary embolism, enabling prompter diagnosis and treatment.

Share

Share on linkedin
Share on twitter
Share on facebook

Main Field

Pulmonology

RSIP Vision’s image processing expertise in medical imaging is currently used in numerous projects, including many applications of computer vision in pulmonology. We are very proud of our contribution to lung medicine: feature detection, lung segmentation and countless other works in the pulmonary imaging field enabled our clients to give the means to physicians to save lives by giving faster and more appropriate treatment to all kind of lung diseases. You can read below about some of our breakthrough developments in Pulmonology and Bronchoscopy.

View Pulmonology

Categories

  • Pulmonology, RSIP Vision Learns

Related Content

Pulmonary embolism

Detecting Pulmonary Embolism from CT Scan

Lung vasculature segmentation

Lung tumors

Lung Tumor Segmentation

Lung Nodules Segmentation

Lung fissures

Lung Fissures Segmentation

Visible lung cancer on CT scan of chest and abdomen

Chest CT Scan Analysis with Deep Learning

Pulmonary embolism

Detecting Pulmonary Embolism from CT Scan

Lung vasculature segmentation

Lung tumors

Lung Tumor Segmentation

Lung Nodules Segmentation

Lung fissures

Lung Fissures Segmentation

Visible lung cancer on CT scan of chest and abdomen

Chest CT Scan Analysis with Deep Learning

Show all

RSIP Vision

Field-tested software solutions and custom R&D, to power your next medical products with innovative AI and image analysis capabilities.

Read more about us

Get in touch

Please fill the following form and our experts will be happy to reply to you soon

Recent News

IBD Scoring – Clario, GI Reviewers and RSIP Vision Team Up

RSIP Neph Announces a Revolutionary Intra-op Solution for Partial Nephrectomy Surgeries

Announcement – RSIP Vision Presents Successful Preliminary Results from Clinical Study of 2D-to-3D Knee Bones Reconstruction

Announcement – New Urological AI Tool for 3D Reconstruction of the Ureter

All news
Upcoming Events
Stay informed for our next events
Subscribe to Our Magazines

Subscribe now and receive the Computer Vision News Magazine every month to your mailbox

 
Subscribe for free
Follow us
Linkedin Twitter Facebook Youtube

contact@rsipvision.com

Terms of Use

Privacy Policy

© All rights reserved to RSIP Vision 2023

Created by Shmulik

  • Our Work
    • title-1
      • Ophthalmology
      • Uncategorized
      • Ophthalmology
      • Pulmonology
      • Cardiology
      • Orthopedics
    • Title-2
      • Orthopedics
  • Success Stories
  • Insights
  • The company